Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
ASST compared with AIM: revenue, margins and what each company keeps, and the suppliers and customers both name
ASST
Strive, Inc.
Change
Mkt cap
Revenue
Revenue
AIM
AIM ImmunoTech Inc.
Change
Mkt cap
Revenue
Revenue
vs
Compare
ASST
Strive, Inc.
vs
AIM
AIM ImmunoTech Inc.
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Revenue flow
Desk
News
Calendar
Saved
Search
ASST
Strive, Inc.
Change
21.44
▲
+4.15%
· post 21.58
Mkt cap
$1.5B
Revenue
$3M
Q3 FY26
Revenue
$4M
FY24
AIM
AIM ImmunoTech Inc.
Change
0.16
▲
+6.25%
· post 0.16
Closed
Nov 6 '26
Mkt cap
$4.7M
Revenue
$26,000
Q2 FY26
Revenue
$88,000
FY25
vs
Compare
Closed
Nov 6 '26
ASST
Strive, Inc.
vs
AIM
AIM ImmunoTech Inc.
21.44
▲
+4.15%
post 21.58
Price
0.16
▲
+6.25%
post 0.16
$1.5B
Mkt cap
$4.7M
Q3 FY26
$3M
Revenue
$26,000
Q2 FY26
FY24
$4M
Revenue
$88,000
FY25
Change
Change
ASST
21.44
▲
+4.15%
vs
AIM
0.16
▲
+6.25%
Closed
Nov 6 '26
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Price
rebased to 0%
1D
1W
1M
3M
YTD
1Y
5Y
1D
1W
1M
3M
YTD
1Y
5Y
ASST, solid
AIM, dashed
Supply-chain overlap
Revenue flow
ASST: latest quarter not drawable. AIM: latest quarter is a loss; flow not drawable.
Method
›
Supply-chain overlap
direct ties · both sides
Sources
›
direct ties · both sides
Only ASST
0
None
Shared
0
No disclosed counterparties: ASST.
Only AIM
1
—
Sterling Pharma Solutions
unlisted
supplier
Role chip = supplier or customer
—
= no ticker (unlisted)
Source: SEC EDGAR